FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Giancarlo Castaman

Research Profile

Disorders

Chemicals & Drugs

Physiology

Concepts & Ideas

Procedures

DNA Mutational Analysis

Co-author Network

Publications

TOP 3
Giancarlo Castaman; Jeroen Eikenboom; Anne Goodeve
Principles of care for the diagnosis and treatment of von Willebrand disease.
J C J Eikenboom; Augusto B Federici; Anne C Goodeve; Jenny Goudemand; Ian R Peake; Francesco Rodeghiero; Reinhard Schneppenheim; Javier Batlle; Ulrich Budde; Maria Teresa Canciani; Giancarlo Castaman; Richard J Dirven
VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease.
Augusto B Federici; Jacob H Rand; Ulrich Budde; Giancarlo Castaman; Andreas Tiede
Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Giancarlo Castaman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Giancarlo Castaman; Jeroen Eikenboom; Anne Goodeve
Principles of care for the diagnosis and treatment of von Willebrand disease.
Haematologica 2013;98(5):667-74.
2013: J C J Eikenboom; Augusto B Federici; Anne C Goodeve; Jenny Goudemand; Ian R Peake; Francesco Rodeghiero; Reinhard Schneppenheim; Javier Batlle; Ulrich Budde; Maria Teresa Canciani; Giancarlo Castaman; Richard J Dirven
VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease.
Blood 2013;121(12):2336-9.
2013: Augusto B Federici; Jacob H Rand; Ulrich Budde; Giancarlo Castaman; Andreas Tiede
Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update.
Seminars in thrombosis and hemostasis 2013;39(2):191-201.
2013: Giancarlo Castaman; A Coppola; A Dragani; Augusto B Federici; G Feola; M Franchini; G Gamba; G Mancuso; G Mazzucconi; S Moratelli; M Musso; Piercarla Schinco; S Siragusa; A Tagliaferri; L Valdrè; E Zanon; G Barillari; C Biasoli; E Boeri; M Morfini
Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease.
Haemophilia : the official journal of the World Federation of Hemophilia 2013;19(1):82-8.
2012: Mirko Pinotti; Giuseppe Tagariello; Donata Belvini; Matteo Campioni; Alessandro Canella; Pierpaolo Caruso; Giancarlo Castaman; Sofia Giacomelli; Francesco Bernardi
Ribosome readthrough accounts for secreted full-length factor IX in hemophilia B patients with nonsense mutations.
Human mutation 2012;33(9):1373-6.
2012: Giancarlo Castaman; Augusto B Federici; S La Marca; P M Mannucci; F Stufano; Alberto Tosetto; Francesco Rodeghiero
Different bleeding risk in type 2A and 2M von Willebrand disease: a 2-year prospective study in 107 patients.
Journal of thrombosis and haemostasis : JTH 2012;10(4):632-8.
2011: Giancarlo Castaman; Alberto Tosetto
Is a reduced intensity treatment with Rituximab effective in acquired haemophilia A?
Haemophilia : the official journal of the World Federation of Hemophilia 2011;17(5):817-8.
2011: Giancarlo Castaman; G D'Andrea; S H Giacomelli; A Goodeve; M E Mancuso; P M Mannucci; S Sanna; Rosa Santacroce; Elena Santagostino; Francesco Rodeghiero
Deep intronic variations may cause mild hemophilia A.
Journal of thrombosis and haemostasis : JTH 2011;9(8):1541-8.
2011: Augusto B Federici; Alfonso Iorio; Luciano Baronciani; Paolo Bucciarelli; Maria T Canciani; Giancarlo Castaman; Maria G Mazzucconi; Massimo Morfini; Emily Oliovecchio; Angiola Rocino; Mario Schiavoni; Pier M Mannucci
Management of inherited von Willebrand disease in Italy: results from the retrospective study on 1234 patients.
Seminars in thrombosis and hemostasis 2011;37(5):511-21.
2011: Alberto Tosetto; Giancarlo Castaman; Iris Plug; Francesco Rodeghiero; J C J Eikenboom
Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation.
Journal of thrombosis and haemostasis : JTH 2011;9(6):1143-8.
2011: Giancarlo Castaman
Treatment of von Willebrand disease with FVIII/VWF concentrates.
Blood transfusion = Trasfusione del sangue 2011;9 Suppl 2():s9-13.
2011: Giancarlo Castaman; Francesco Rodeghiero
Advances in the diagnosis and management of type 1 von Willebrand disease.
Expert review of hematology 2011;4(1):95-106.
2010: Giancarlo Castaman; M Platè; S H Giacomelli; Francesco Rodeghiero; Stefano Duga
Alterations of mRNA processing and stability as a pathogenic mechanism in von Willebrand factor quantitative deficiencies.
Journal of thrombosis and haemostasis : JTH 2010;8(12):2736-42.
2010: Giancarlo Castaman; Alberto Tosetto; Anne C Goodeve; Augusto B Federici; Stefan Lethagen; Ulrich Budde; Javier Batlle; Dominique Meyer; Claudine Mazurier; Jenny Goudemand; Jeroen Eikenboom; Reinhard Schneppenheim; Jørgen Ingerslev; David Habart; Frank Hill; Ian R Peake; Francesco Rodeghiero
The impact of bleeding history, von Willebrand factor and PFA-100(®) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD.
British journal of haematology 2010;151(3):245-51.
2010: Giancarlo Castaman; Alberto Tosetto; A Cappelletti; A Goodeve; Augusto B Federici; J Batlle; D Meyer; J Goudemand; J C J Eikenboom; Reinhard Schneppenheim; U Budde; Jørgen Ingerslev; Stefan Lethagen; F Hill; I R Peake; Francesco Rodeghiero
Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWD.
Thrombosis research 2010;126(3):227-31.
2010: Giancarlo Castaman; Alberto Tosetto; J C J Eikenboom; Francesco Rodeghiero
Blood group significantly influences von Willebrand factor increase and half-life after desmopressin in von Willebrand disease Vicenza.
Journal of thrombosis and haemostasis : JTH 2010;8(9):2078-80.
2010: N Hickson; D Hampshire; Peter R Winship; Jenny Goudemand; Reinhard Schneppenheim; Ulrich Budde; Giancarlo Castaman; Francesco Rodeghiero; Augusto B Federici; P James; Ian R Peake; J C J Eikenboom; Anne C Goodeve
von Willebrand factor variant p.Arg924Gln marks an allele associated with reduced von Willebrand factor and factor VIII levels.
Journal of thrombosis and haemostasis : JTH 2010;8(9):1986-93.
2010: Giancarlo Castaman; Alberto Tosetto; Francesco Rodeghiero
Pregnancy and delivery in women with von Willebrand's disease and different von Willebrand factor mutations.
Haematologica 2010;95(6):963-9.
2009: Silvia Spena; Rosanna Asselta; Sonia Caccia; Valeria Rimoldi; Sofia H Giacomelli; Annarita Tagliaferri; Flora Peyvandi; Giancarlo Castaman; Stefano Duga
Analysis of the structural effects of four novel and a previously known mutations causing factor XI deficiency.
Thrombosis and haemostasis 2009;102(3):603-6.
2009: Francesco Rodeghiero; Giancarlo Castaman; Alberto Tosetto
How I treat von Willebrand disease.
Blood 2009;114(6):1158-65.
2009: J C J Eikenboom; L Hilbert; A S Ribba; A Hommais; David Habart; S Messenger; A Al-Buhairan; A Guilliatt; W Lester; Claudine Mazurier; Dominique Meyer; Edith Fressinaud; Ulrich Budde; K Will; Reinhard Schneppenheim; T Obser; O Marggraf; E Eckert; Giancarlo Castaman; Francesco Rodeghiero; Augusto B Federici; Javier Batlle; Jenny Goudemand; Jørgen Ingerslev; Stefan Lethagen; Frank Hill; Ian R Peake; Anne C Goodeve
Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study.
Journal of thrombosis and haemostasis : JTH 2009;7(8):1304-12.
2009: Giancarlo Castaman; Alberto Tosetto; Francesco Rodeghiero
Reduced von Willebrand factor survival in von Willebrand disease: pathophysiologic and clinical relevance.
Journal of thrombosis and haemostasis : JTH 2009;7 Suppl 1():71-4.
2009: Manuela Platè; Stefano Duga; Giancarlo Castaman; Francesco Rodeghiero; Rosanna Asselta
Recurrence of the 'deep-intronic' FGG IVS6-320A>T mutation causing quantitative fibrinogen deficiency in the Italian population of Veneto.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2009;20(5):381-4.
2009: Pier Mannuccio Mannucci; Massimo Franchini; Giancarlo Castaman; Augusto B Federici
Evidence-based recommendations on the treatment of von Willebrand disease in Italy.
Blood transfusion = Trasfusione del sangue 2009;7(2):117-26.
2009: Giancarlo Castaman; M Lunardi; L Rigo; V Mastroeni; E Bonoldi; Francesco Rodeghiero
Severe spontaneous arterial thrombotic manifestations in patients with inherited hypo- and afibrinogenemia.
Haemophilia : the official journal of the World Federation of Hemophilia 2009;15(2):533-7.
2009: Augusto B Federici; Pier M Mannucci; Giancarlo Castaman; Luciano Baronciani; Paolo Bucciarelli; Maria Teresa Canciani; Alessandro Pecci; Peter J Lenting; Philip G de Groot
Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients.
Blood 2009;113(3):526-34.
2009: Francesco Rodeghiero; Giancarlo Castaman; Alberto Tosetto
Optimizing treatment of von Willebrand disease by using phenotypic and molecular data.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2009;():113-23.
2009: Giancarlo Castaman; S Giacomelli; Francesco Rodeghiero
Autosomal recessive von Willebrand disease type 1 or 2 due to homozygous or compound heterozygous mutations in the von Willebrand factor gene. A single center experience on molecular heterogeneity and laboratory features in 12 families.
Acta haematologica 2009;121(2-3):106-10.
2008: Giancarlo Castaman; Sofia H Giacomelli; David Habart; Rosanna Asselta; Stefano Duga; Francesco Rodeghiero
Factor XI gene mutations in factor XI deficient patients of the Czech Republic.
American journal of hematology 2008;83(12):916-9.
2008: Giancarlo Castaman; Sofia H Giacomelli; Alfredo Dragani; Ornella Iuliani; Stefano Duga; Francesco Rodeghiero
Severe factor XI deficiency in the Abruzzo region of Italy is associated to different FXI gene mutations.
Haematologica 2008;93(6):957-8.
2008: Sandra L Haberichter; Giancarlo Castaman; Ulrich Budde; Ian Peake; Anne Goodeve; Francesco Rodeghiero; Augusto B Federici; Javier Batlle; Dominique Meyer; Claudine Mazurier; Jenny Goudemand; Jeroen Eikenboom; Reinhard Schneppenheim; Jørgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; Stefan Lethagen; John Pasi; Frank G H Hill; Robert R Montgomery
Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).
Blood 2008;111(10):4979-85.
2008: Giorgia Zadra; Rosanna Asselta; Maria Luisa Tenchini; Giancarlo Castaman; Uri Seligsohn; Pier Mannuccio Mannucci; Stefano Duga
Simultaneous genotyping of coagulation factor XI type II and type III mutations by multiplex real-time polymerase chain reaction to determine their prevalence in healthy and factor XI-deficient Italians.
Haematologica 2008;93(5):715-21.
2008: Maurizio Margaglione; Giancarlo Castaman; Massimo Morfini; Angiola Rocino; Elena Santagostino; Giuseppe Tagariello; Anna Rita Tagliaferri; Ezio Zanon; Maria Patrizia Bicocchi; Giuseppe Castaldo; Flora Peyvandi; Rosa Santacroce; Francesca Torricelli; Elvira Grandone; Pier Mannuccio Mannucci
The Italian AICE-Genetics hemophilia A database: results and correlation with clinical phenotype.
Haematologica 2008;93(5):722-8.
2008: Alberto Tosetto; Giancarlo Castaman; Francesco Rodeghiero
Bleeding scores in inherited bleeding disorders: clinical or research tools?
Haemophilia : the official journal of the World Federation of Hemophilia 2008;14(3):415-22.
2008: Alberto Tosetto; Giancarlo Castaman; Francesco Rodeghiero
Evidence-based diagnosis of type 1 von Willebrand disease: a Bayes theorem approach.
Blood 2008;111(8):3998-4003.
2008: Giancarlo Castaman; Stefan Lethagen; Augusto B Federici; Alberto Tosetto; Anne Goodeve; Ulrich Budde; Javier Batlle; Dominique Meyer; Claudine Mazurier; Edith Fressinaud; Jenny Goudemand; Jeroen Eikenboom; Reinhard Schneppenheim; Jørgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; John Pasi; Frank Hill; Ian Peake; Francesco Rodeghiero
Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD.
Blood 2008;111(7):3531-9.
2008: Francesca Scognamiglio; Chiara Corso; domenico madeo; Giancarlo Castaman; Carlo Visco; Carlo Borghero; Marco Ruggeri; Francesco Rodeghiero
Flow cytometry in the diagnosis of drug-induced thrombocytopenia: two illustrative cases.
American journal of hematology 2008;83(4):326-9.
2008: Ilaria Guella; Giulia Soldà; Silvia Spena; Rosanna Asselta; Rossella Ghiotto; Maria Luisa Tenchini; Giancarlo Castaman; Stefano Duga
Molecular characterization of two novel mutations causing factor XI deficiency: A splicing defect and a missense mutation responsible for a CRM+ defect.
Thrombosis and haemostasis 2008;99(3):523-30.
2008: Marco Ruggeri; Francesco Rodeghiero; Alberto Tosetto; Giancarlo Castaman; Francesca Scognamiglio; Guido Finazzi; Federica Delaini; Caterina Micò; Alessandro M Vannucchi; Elisabetta Antonioli; Valerio De Stefano; Tommaso Za; Luigi Gugliotta; Alessia Tieghi; Maria Gabriella Mazzucconi; Cristina Santoro; Tiziano Barbui
Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective survey.
Blood 2008;111(2):666-71.
2008: Giancarlo Castaman; S H Giacomelli; Vytautas Ivaskevicius; V Schroeder; H P Kohler; A Dragani; C Biasioli; Johannes Oldenburg; domenico madeo; Francesco Rodeghiero
Molecular characterization of five Italian families with inherited severe factor XIII deficiency.
Haemophilia : the official journal of the World Federation of Hemophilia 2008;14(1):96-102.
2008: Giancarlo Castaman; Sofia H Giacomelli; Rossella Ghiotto; Keti Pojani; Francesco Rodeghiero
First factor IX mutations in Albanian hemophilia B patients.
American journal of hematology 2008;83(1):88-9.
2007: Cristina Bozzao; Valeria Rimoldi; Rosanna Asselta; Meytal Landau; Rossella Ghiotto; Maria Luisa Tenchini; Raimondo De Cristofaro; Giancarlo Castaman; Stefano Duga
A novel factor XI missense mutation (Val371Ile) in the activation loop is responsible for a case of mild type II factor XI deficiency.
The FEBS journal 2007;274(23):6128-38.
2007: Silvia Spena; Rosanna Asselta; Manuela Platé; Giancarlo Castaman; Stefano Duga; Maria Luisa Tenchini
Pseudo-exon activation caused by a deep-intronic mutation in the fibrinogen gamma-chain gene as a novel mechanism for congenital afibrinogenaemia.
British journal of haematology 2007;139(1):128-32.
2007: Francesco Rodeghiero; Alberto Tosetto; Giancarlo Castaman
How to estimate bleeding risk in mild bleeding disorders.
Journal of thrombosis and haemostasis : JTH 2007;5 Suppl 1():157-66.
2007: Roberta Salviato; Donata Belvini; Paolo Radossi; Roberto Sartori; F Pierobon; Daniela Zanotto; Ezio Zanon; Giancarlo Castaman; G Gandini; Giuseppe Tagariello
F8 gene mutation profile and ITT response in a cohort of Italian haemophilia A patients with inhibitors.
Haemophilia : the official journal of the World Federation of Hemophilia 2007;13(4):361-72.
2007: Augusto B Federici; Giancarlo Castaman; Massimo Franchini; Massimo Morfini; Ezio Zanon; Antonio Coppola; Annarita Tagliaferri; Elio Boeri; Maria Gabriella Mazzucconi; Gina Rossetti; Pier Mannuccio Mannucci
Clinical use of Haemate P in inherited von Willebrand's disease: a cohort study on 100 Italian patients.
Haematologica 2007;92(7):944-51.
2007: Giancarlo Castaman; S H Giacomelli; Rossella Ghiotto; C Boseggia; K Pojani; A Bulo; domenico madeo; Francesco Rodeghiero
Spectrum of mutations in Albanian patients with haemophilia A: identification of ten novel mutations in the factor VIII gene.
Haemophilia : the official journal of the World Federation of Hemophilia 2007;13(3):311-6.
2007: Giancarlo Castaman; K Bertoncello; M Bernardi; J C J Eikenboom; Ulrich Budde; Francesco Rodeghiero
Autosomal recessive von Willebrand disease associated with compound heterozygosity for a novel nonsense mutation (2908 del C) and the missense mutation C2362F: definite evidence for the non-penetrance of the C2362F mutation.
American journal of hematology 2007;82(5):376-80.
2007: Alberto Tosetto; Francesco Rodeghiero; Giancarlo Castaman; M Bernardi; K Bertoncello; Anne C Goodeve; Augusto B Federici; Javier Batlle; Dominique Meyer; Claudine Mazurier; Jenny Goudemand; J C J Eikenboom; Reinhard Schneppenheim; Ulrich Budde; Jørgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; Stefan Lethagen; John Pasi; Frank Hill; Ian R Peake
Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD).
Journal of thrombosis and haemostasis : JTH 2007;5(4):715-21.
2007: Ermanna Rovida; Giuliana Merati; Pasqualina D'Ursi; Sara Zanardelli; Francesca Marino; Gessica Fontana; Giancarlo Castaman; Elena M Faioni
Identification and computationally-based structural interpretation of naturally occurring variants of human protein C.
Human mutation 2007;28(4):345-55.
2007: Alberto Tosetto; Giancarlo Castaman; Francesco Rodeghiero
Assessing bleeding in von Willebrand disease with bleeding score.
Blood reviews 2007;21(2):89-97.
2007: Giancarlo Castaman; Eugenia Biguzzi; Cristina Razzari; Alberto Tosetto; Gessica Fontana; Daniela Asti; Vincenzo Brancaccio; D Castori; David A Lane; Elena M Faioni
Association of protein S p.Pro667Pro dimorphism with plasma protein S levels in normal individuals and patients with inherited protein S deficiency.
Thrombosis research 2007;120(3):421-6.
2007: Anne C Goodeve; J C J Eikenboom; Giancarlo Castaman; Francesco Rodeghiero; Augusto B Federici; Javier Batlle; Dominique Meyer; Claudine Mazurier; Jenny Goudemand; Reinhard Schneppenheim; Ulrich Budde; Jørgen Ingerslev; David Habart; Zdena Vorlova; Lars Holmberg; Stefan Lethagen; John Pasi; Frank Hill; Mohammad Hashemi Soteh; Luciano Baronciani; Christer Hallden; Andrea M Guilliatt; William A Lester; Ian R Peake
Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD).
Blood 2007;109(1):112-21.
2006: Giancarlo Castaman; Francesco Rodeghiero; Alberto Tosetto; A Cappelletti; Francesco Baudo; J C J Eikenboom; Augusto B Federici; Stefan Lethagen; S Linari; Jeanne M Lusher; M Nishino; P Petrini; A Srivastava; J S Ungerstedt
Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study.
Journal of thrombosis and haemostasis : JTH 2006;4(10):2164-9.
2006: Massimo Franchini; D Girelli; O Olivieri; Giancarlo Castaman; Giuseppe Lippi; G Poli; G L Salvagno; Giuseppe Tagariello; Annachiara Giuffrida; Marzia De Gironcoli; Massimo Morfini; E Berntorp; Giorgio Gandini
Tyr2105Cys mutation in exon 22 of FVIII gene is a risk factor for the development of inhibitors in patients with mild/moderate haemophilia A.
Haemophilia : the official journal of the World Federation of Hemophilia 2006;12(4):448-51.
2006: Augusto B Federici; Giancarlo Castaman; A Thompson; Erik Berntorp
Von Willebrand's disease: clinical management.
Haemophilia : the official journal of the World Federation of Hemophilia 2006;12 Suppl 3():152-8.
2006: Pernilla Tjernberg; Giancarlo Castaman; Hans L Vos; Rogier M Bertina; J C J Eikenboom
Homozygous C2362F von Willebrand factor induces intracellular retention of mutant von Willebrand factor resulting in autosomal recessive severe von Willebrand disease.
British journal of haematology 2006;133(4):409-18.
2006: J C J Eikenboom; Vincent Van Marion; H Putter; Anne C Goodeve; Francesco Rodeghiero; Giancarlo Castaman; Augusto B Federici; Javier Batlle; Dominique Meyer; Claudine Mazurier; Jenny Goudemand; Reinhard Schneppenheim; Ulrich Budde; Jørgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; Stefan Lethagen; John Pasi; Frank Hill; Ian R Peake
Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD.
Journal of thrombosis and haemostasis : JTH 2006;4(4):774-82.
2006: Alberto Tosetto; Francesco Rodeghiero; Giancarlo Castaman; Anne C Goodeve; Augusto B Federici; Javier Batlle; Dominique Meyer; Edith Fressinaud; Claudine Mazurier; Jenny Goudemand; J C J Eikenboom; Reinhard Schneppenheim; Ulrich Budde; Jørgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; Stefan Lethagen; John Pasi; Frank Hill; Ian R Peake
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD).
Journal of thrombosis and haemostasis : JTH 2006;4(4):766-73.
2006: Giancarlo Castaman; Augusto B Federici; M Bernardi; B Moroni; K Bertoncello; Francesco Rodeghiero
Factor VIII and von Willebrand factor changes after desmopressin and during pregnancy in type 2M von Willebrand disease Vicenza: a prospective study comparing patients with single (R1205H) and double (R1205H-M740I) defect.
Journal of thrombosis and haemostasis : JTH 2006;4(2):357-60.
2005: Francesco Rodeghiero; Giancarlo Castaman; Alberto Tosetto; Javier Batlle; Francesco Baudo; A Cappelletti; P Casana; N De Bosch; J C J Eikenboom; Augusto B Federici; Stefan Lethagen; S Linari; A Srivastava
The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study.
Journal of thrombosis and haemostasis : JTH 2005;3(12):2619-26.
2005: Giulia Soldà; Rosanna Asselta; Rossella Ghiotto; Maria Luisa Tenchini; Giancarlo Castaman; Stefano Duga
A type II mutation (Glu117stop), induction of allele-specific mRNA degradation and factor XI deficiency.
Haematologica 2005;90(12):1716-8.
2005: C J Schooten; Pernilla Tjernberg; Erik Westein; Virginie Terraube; Giancarlo Castaman; J A Mourik; Martine J Hollestelle; Hans L Vos; Rogier M Bertina; H M Berg; J C J Eikenboom; Peter J Lenting; Cécile V Denis
Cysteine-mutations in von Willebrand factor associated with increased clearance.
Journal of thrombosis and haemostasis : JTH 2005;3(10):2228-37.
2005: Giancarlo Castaman; Rossella Ghiotto; Stefano Duga; Francesco Rodeghiero
A novel fibrinogen gamma chain mutation (gamma 239 Gln-->His) is the cause of dysfibrinogenemia Vicenza.
Journal of thrombosis and haemostasis : JTH 2005;3(3):600-1.
2005: Eugenia Biguzzi; Cristina Razzari; David A Lane; Giancarlo Castaman; Antonio Cappellari; Paolo Bucciarelli; Gessica Fontana; Maurizio Margaglione; Giovanna D'Andrea; Rachel E Simmonds; Suely M Rezende; Roger Preston; Domenico Prisco; Elena M Faioni
Molecular diversity and thrombotic risk in protein S deficiency: the PROSIT study.
Human mutation 2005;25(3):259-69.
2005: Giancarlo Castaman; Rossella Ghiotto; Alberto Tosetto; Francesco Rodeghiero
Bbeta 14 Arg --> Cys variant dysfibrinogen and its association with thrombosis.
Journal of thrombosis and haemostasis : JTH 2005;3(2):409-10.
2005: Giancarlo Castaman; K Bertoncello; M Bernardi; Francesco Rodeghiero
Pregnancy and delivery in patients with homozygous or heterozygous R854Q type 2N von Willebrand disease.
Journal of thrombosis and haemostasis : JTH 2005;3(2):391-2.
2005: Francesco Rodeghiero; Giancarlo Castaman
Treatment of von Willebrand disease.
Seminars in hematology 2005;42(1):29-35.
2004: Elisabetta Novella; domenico madeo; Elena Albiero; Sara Roberti; Giancarlo Castaman; Francesca Elice; Francesco Rodeghiero
Effect of DCEP mobilizing regimen in in vivo purging of PBSC harvests in multiple myeloma.
Leukemia & lymphoma 2004;45(7):1497-9.
2004: Cecilia Gelfi; Agnese Viganò; Marilena Ripamonti; Robin Wait; Shajna Begum; Eugenia Biguzzi; Giancarlo Castaman; Elena M Faioni
A proteomic analysis of changes in prothrombin and plasma proteins associated with the G20210A mutation.
Proteomics 2004;4(7):2151-9.
2004: Rosanna Asselta; Stefano Duga; Silvia Spena; Flora Peyvandi; Giancarlo Castaman; Massimo Malcovati; Pier Mannuccio Mannucci; Maria Luisa Tenchini
Missense or splicing mutation? The case of a fibrinogen Bbeta-chain mutation causing severe hypofibrinogenemia.
Blood 2004;103(8):3051-4.
2004: A Srámek; Paolo Bucciarelli; Augusto B Federici; Pier M Mannucci; V De Rosa; Giancarlo Castaman; Massimo Morfini; Maria Gabriella Mazzucconi; Angiola Rocino; Mario Schiavoni; FA Scaraggi; Johan H C Reiber; Frits R Rosendaal
Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis: results from a multicenter study in 47 patients.
Circulation 2004;109(6):740-4.
2004: Elena M Faioni; Giancarlo Castaman; Daniela Asti; Federico Lussana; Francesco Rodeghiero
Association of factor V deficiency with factor V HR2.
Haematologica 2004;89(2):195-200.
2004: Pernilla Tjernberg; Hans L Vos; Giancarlo Castaman; Rogier M Bertina; J C J Eikenboom
Dimerization and multimerization defects of von Willebrand factor due to mutated cysteine residues.
Journal of thrombosis and haemostasis : JTH 2004;2(2):257-65.
2003: Giancarlo Castaman; Elena M Faioni; Alberto Tosetto; Francesco Bernardi
The factor V HR2 haplotype and the risk of venous thrombosis: a meta-analysis.
Haematologica 2003;88(10):1182-9.
2003: domenico madeo; Antonio Cappellari; Giancarlo Castaman; Roberto Raimondi; Francesco Rodeghiero
Multiplex amplification and fluorimetric detection of short tandem repeats for mixed chimerism after bone marrow transplant.
Leukemia & lymphoma 2003;44(8):1395-404.
2003: Giovanna D'Andrea; Pasquale Di Perna; Vincenzo Brancaccio; Elena M Faioni; Giancarlo Castaman; Giuseppe Cibelli; Giovanni Di Minno; Maurizio Margaglione
A novel G-to-A mutation in the intron-N of the protein S gene leading to abnormal RNA splicing in a patient with protein S deficiency.
Haematologica 2003;88(4):459-64.
2003: Giancarlo Castaman; Augusto B Federici; Francesco Rodeghiero; Pier Mannuccio Mannucci
Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.
Haematologica 2003;88(1):94-108.
2002: Elisabetta Novella; Ilaria Giaretta; Francesca Elice; domenico madeo; Andrea Piccin; Giancarlo Castaman; Francesco Rodeghiero
Fluorescent polymerase chain reaction and capillary electrophoresis for IgH rearrangement and minimal residual disease evaluation in multiple myeloma.
Haematologica 2002;87(11):1157-64.
2002: Giancarlo Castaman; Elisabetta Novella; Laura Contino; Marta Demicheli; Francesco Rodeghiero
First Italian families with homozygous R854Q type 2 N von Willebrand disease.
Thrombosis and haemostasis 2002;88(3):534-5.
2002: Marco Ruggeri; Heinz Gisslinger; Alberto Tosetto; Claudia Rintelen; Christine Mannhalter; Ingrid Pabinger; Navide Heis; Giancarlo Castaman; Edoardo Missiaglia; Klaus Lechner; Francesco Rodeghiero
Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
American journal of hematology 2002;71(1):1-6.
2002: Giancarlo Castaman; J C J Eikenboom
ABO blood group also influences the von Willebrand factor (VWF) antigen level in heterozygous carriers of VWF null alleles, type 2N mutation Arg854GIn, and the missense mutation Cys2362Phe.
Blood 2002;100(5):1927-8.
2002: Augusto B Federici; Giancarlo Castaman; Pier M Mannucci
Guidelines for the diagnosis and management of von Willebrand disease in Italy.
Haemophilia : the official journal of the World Federation of Hemophilia 2002;8(5):607-21.
2002: Elena M Faioni; Franca Franchi; Giancarlo Castaman; Eugenia Biguzzi; Francesco Rodeghiero
Mutations in the thrombomodulin gene are rare in patients with severe thrombophilia.
British journal of haematology 2002;118(2):595-9.
2002: Giancarlo Castaman; Francesco Rodeghiero; Pier Mannuccio Mannucci
The elusive pathogenesis of von Willebrand disease Vicenza.
Blood 2002;99(11):4243-4; author reply 4244.
2002: J C J Eikenboom; Giancarlo Castaman; Pieter W Kamphuisen; Frits R Rosendaal; Rogier M Bertina
The factor VIII/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factor.
Thrombosis and haemostasis 2002;87(2):252-7.
2002: Giancarlo Castaman; Elisabetta Novella; Evelina Castiglia; J C J Eikenboom; Francesco Rodeghiero
A novel family with recessive von Willebrand disease due to compound heterozygosity for a splice site mutation and a missense mutation in the von Willebrand factor gene.
Thrombosis research 2002;105(2):135-8.
2001: Alberta Azzi; R De Santis; Massimo Morfini; Krystyna Zakrzewska; Roberto Musso; Elena Santagostino; Giancarlo Castaman
TT virus contaminates first-generation recombinant factor VIII concentrates.
Blood 2001;98(8):2571-3.
2001: Giancarlo Castaman; Alberto Tosetto; M Simioni; M Ruggeri; domenico madeo; Francesco Rodeghiero
Phenotypic APC resistance in carriers of the A20210 prothrombin mutation is associated with an increased risk of venous thrombosis.
Thrombosis and haemostasis 2001;86(3):804-8.
2000: Ida Martinelli; Paolo Bucciarelli; Maurizio Margaglione; Valerio De Stefano; Giancarlo Castaman; Pier M Mannucci
The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both.
British journal of haematology 2000;111(4):1223-9.
2000: Alberto Tosetto; Giancarlo Castaman; Antonio Cappellari; Francesco Rodeghiero
The VITA Project: heritability of resistance to activated protein C. Vincenza Thrombophilia and Arteriosclerosis.
Thrombosis and haemostasis 2000;84(5):811-4.
2000: Giancarlo Castaman; Edoardo Missiaglia; A B Federici; R Schneppenheim; Francesco Rodeghiero
An additional unique candidate mutation (G2470A; M740I) in the original families with von Willebrand disease type 2 M Vicenza and the G3864A (R1205H) mutation.
Thrombosis and haemostasis 2000;84(2):350-1.
2000: Giancarlo Castaman; Alberto Tosetto; Antonio Cappellari; M Ruggeri; Francesco Rodeghiero
The A20210 allele in the prothrombin gene enhances the risk of venous thrombosis in carriers of inherited protein S deficiency.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2000;11(4):321-6.
2000: Giancarlo Castaman; J C Eikenboom; Edoardo Missiaglia; Francesco Rodeghiero
Autosomal dominant type 1 von willebrand disease due to G3639T mutation (C1130F) in exon 26 of von Willebrand factor gene: description of five Italian families and evidence for a founder effect.
British journal of haematology 2000;108(4):876-9.
2000: Giancarlo Castaman; J C J Eikenboom; A Lattuada; Pier M Mannucci; Francesco Rodeghiero
Heightened proteolysis of the von Willebrand factor subunit in patients with von Willebrand disease hemizygous or homozygous for the C2362F mutation.
British journal of haematology 2000;108(1):188-90.
1999: Elena M Faioni; Franca Franchi; Paolo Bucciarelli; Maurizio Margaglione; Valerio De Stefano; Giancarlo Castaman; G Finazzi; Pier M Mannucci
Coinheritance of the HR2 haplotype in the factor V gene confers an increased risk of venous thromboembolism to carriers of factor V R506Q (factor V Leiden).
Blood 1999;94(9):3062-6.
1998: Augusto B Federici; F Stabile; Giancarlo Castaman; Maria Teresa Canciani; Pier M Mannucci
Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches.
Blood 1998;92(8):2707-11.
1998: Barbara Lunghi; Elisabetta Castoldi; Federico Mingozzi; francesco bernardi; Giancarlo Castaman
A novel factor V null mutation detected in a thrombophilic patient with pseudo-homozygous APC resistance and in an asymptomatic unrelated subject.
Blood 1998;92(4):1463-4.
1998: J C J Eikenboom; Giancarlo Castaman; Hans L Vos; Rogier M Bertina; Francesco Rodeghiero
Characterization of the genetic defects in recessive type 1 and type 3 von Willebrand disease patients of Italian origin.
Thrombosis and haemostasis 1998;79(4):709-17.
1998: Giancarlo Castaman; M Ruggeri; Alberto Tosetto; Francesco Rodeghiero
Low risk of venous thrombosis in two families with combined type I plasminogen deficiency and factor V R506Q mutation.
American journal of hematology 1998;57(4):344-7.
1997: R Vangelisti; O Pagnacco; G Ristagno; M Ruggeri; Alberto Tosetto; Giancarlo Castaman; Francesco Rodeghiero
[Prevention of hemorrhage and dental treatment of patients with congenital or acquired coagulopathies].
Minerva stomatologica 1997;46(11):621-6.
1997: Giancarlo Castaman; Barbara Lunghi; Edoardo Missiaglia; F Bernardi; Francesco Rodeghiero
Phenotypic homozygous activated protein C resistance associated with compound heterozygosity for Arg506Gln (factor V Leiden) and His1299Arg substitutions in factor V.
British journal of haematology 1997;99(2):257-61.
1997: Alberto Tosetto; M Ruggeri; Giancarlo Castaman; Francesco Rodeghiero
Inherited abnormalities of blood coagulation in juvenile stroke. A case-control study.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1997;8(7):397-402.
1997: Giancarlo Castaman; E D Bona; C Schiavotto; L Trentin; Anna D'Emilio; Francesco Rodeghiero
Pilot study on the safety and efficacy of desmopressin for the treatment or prevention of bleeding in patients with hematologic malignancies.
Haematologica 1997;82(5):584-7.
1997: francesco bernardi; Elena M Faioni; Elisabetta Castoldi; Barbara Lunghi; Giancarlo Castaman; E Sacchi; P M Mannucci
A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype.
Blood 1997;90(4):1552-7.
1997: M Ruggeri; C Schiavotto; Giancarlo Castaman; Alberto Tosetto; Francesco Rodeghiero
Gestational thrombocytopenia: a prospective study.
Haematologica 1997;82(3):341-2.
1997: Giancarlo Castaman; L Yu-Feng; E Battistin; Francesco Rodeghiero
Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generation.
British journal of haematology 1997;96(3):458-63.
1996: Francesco Rodeghiero; Giancarlo Castaman; P M Mannucci
Prospective multicenter study on subcutaneous concentrated desmopressin for home treatment of patients with von Willebrand disease and mild or moderate hemophilia A.
Thrombosis and haemostasis 1996;76(5):692-6.
1996: Giancarlo Castaman; M Ruggeri; Alberto Tosetto; Edoardo Missiaglia; Francesco Rodeghiero
Thrombosis in patients with heterozygous and homozygous factor XII deficiency is not explained by the associated presence of factor V Leiden.
Thrombosis and haemostasis 1996;76(2):275.
1996: Giancarlo Castaman; M Ruggeri; Francesco Rodeghiero
Clinical usefulness of desmopressin for prevention of surgical bleeding in patients with symptomatic heterozygous factor XI deficiency.
British journal of haematology 1996;94(1):168-70.
1996: C Schiavotto; M Ruggeri; Giancarlo Castaman; Francesco Rodeghiero
High-dose dexamethasone in adult refractory idiopathic thrombocytopenic purpura.
British journal of haematology 1996;93(2):491-2.
1996: francesco bernardi; Giancarlo Castaman; Mirko Pinotti; Paolo Ferraresi; M G Di Iasio; Barbara Lunghi; F Rodeghiero; Giovanna Marchetti
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency.
Human mutation 1996;8(2):108-15.
1996: Barbara Lunghi; Licia Iacoviello; Donato Gemmati; M G Dilasio; Elisabetta Castoldi; Mirko Pinotti; Giancarlo Castaman; Rosaria Redaelli; Guglielmo Mariani; Giovanna Marchetti; francesco bernardi
Detection of new polymorphic markers in the factor V gene: association with factor V levels in plasma.
Thrombosis and haemostasis 1996;75(1):45-8.
1995: Giancarlo Castaman; Francesco Rodeghiero
Current management of von Willebrand's disease.
Drugs 1995;50(4):602-14.
1995: Giovanna Marchetti; Giancarlo Castaman; Mirko Pinotti; Barbara Lunghi; M G Di Iasio; M Ruggieri; F Rodeghiero; francesco bernardi
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glu102Lys) in the second EGF-like domain.
British journal of haematology 1995;90(4):910-5.
1995: Giancarlo Castaman; A Lattuada; M Ruggeri; Alberto Tosetto; P M Mannucci; Francesco Rodeghiero
Platelet von Willebrand factor abnormalities in myeloproliferative syndromes.
American journal of hematology 1995;49(4):289-93.
1995: Giancarlo Castaman; A Lattuada; P M Mannucci; Francesco Rodeghiero
Factor VIII:C increases after desmopressin in a subgroup of patients with autosomal recessive severe von Willebrand disease.
British journal of haematology 1995;89(1):147-51.
1994: francesco bernardi; Giancarlo Castaman; Rosaria Redaelli; Mirko Pinotti; Barbara Lunghi; F Rodeghiero; Giovanna Marchetti
Topologically equivalent mutations causing dysfunctional coagulation factors VII (294Ala-->Val) and X (334Ser-->Pro).
Human molecular genetics 1994;3(7):1175-7.
1994: Francesco Rodeghiero; Giancarlo Castaman
The pathophysiology and treatment of hemorrhagic syndrome of acute promyelocytic leukemia.
Leukemia 1994;8 Suppl 2():S20-6.
1993: Giancarlo Castaman; Francesco Rodeghiero; A Lattuada; G La Greca; P M Mannucci
Multimeric pattern of plasma and platelet von Willebrand factor is normal in uremic patients.
American journal of hematology 1993;44(4):266-9.
1993: M Frezzato; Giancarlo Castaman; Francesco Rodeghiero
Fulminant sepsis in adults splenectomized for Hodgkin's disease.
Haematologica 1993;78(6 Suppl 2):73-7.
1993: Giancarlo Castaman; Francesco Rodeghiero
Erwinia- and E. coli-derived L-asparaginase have similar effects on hemostasis. Pilot study in 10 patients with acute lymphoblastic leukemia.
Haematologica 1993;78(6 Suppl 2):57-60.
1993: Giancarlo Castaman; E Galloni; A V Dri; Francesco Rodeghiero
Fibrinogen survival and fibrinopeptide A in acute leukemia.
Haematologica 1993;78(6 Suppl 2):52-6.
1993: Alberto Tosetto; Giancarlo Castaman; Francesco Rodeghiero
Acquired plasma factor XIII deficiencies.
Haematologica 1993;78(6 Suppl 2):5-10.
1993: M Ruggeri; M Milan; G La Greca; Giancarlo Castaman; Francesco Rodeghiero
Adult patients with the nephrotic syndrome: really at high risk for deep venous thromboembolism? Report of a series and review of the literature.
Haematologica 1993;78(6 Suppl 2):47-51.
1993: C Schiavotto; Giancarlo Castaman; Francesco Rodeghiero
Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol.
Haematologica 1993;78(6 Suppl 2):29-34.
1993: M Ruggeri; Giancarlo Castaman; Francesco Rodeghiero
Is ticlopidine a safe alternative to aspirin for management of myeloproliferative disorders?
Haematologica 1993;78(6 Suppl 2):18-21.
1993: M Frezzato; M Ruggeri; Giancarlo Castaman; Francesco Rodeghiero
Polycythemia vera and essential thrombocythemia in young patients.
Haematologica 1993;78(6 Suppl 2):11-7.
1993: Giovanna Marchetti; P Patracchini; Donato Gemmati; Giancarlo Castaman; F Rodeghiero; A Wacey; D N Cooper; E G Tuddenham; francesco bernardi
Symptomatic type II protein C deficiency caused by a missense mutation (Gly 381-->Ser) in the substrate-binding pocket.
British journal of haematology 1993;84(2):285-9.
1993: Giancarlo Castaman; Francesco Rodeghiero; A Lattuada; P M Mannucci
Desmopressin-induced thrombocytopenia in type I platelet discordant von Willebrand disease.
American journal of hematology 1993;43(1):5-9.
1993: Giancarlo Castaman; Francesco Rodeghiero
Consistency of responses to separate desmopressin infusions in patients with storage pool disease and isolated prolonged bleeding time.
Thrombosis research 1993;69(4):407-12.
1993: Francesco Rodeghiero; Giancarlo Castaman; Luigi Gugliotta; Monica Mattioli Belmonte; A Falanga; B Bottasso; T Barbui; P M Mannucci
Supranormal antithrombin III levels induced by concentrate administration are ineffective in quenching thrombin generation in acute promyelocytic leukemia.
Thrombosis research 1993;69(4):377-85.
1993: Giancarlo Castaman; M Ruggeri; Francesco Rodeghiero
Histidine-rich glycoprotein changes during pregnancy in a woman with genetically transmitted high levels of the protein and thrombotic diathesis.
Thrombosis research 1993;69(3):329-32.
1993: Giancarlo Castaman; M Ruggeri; F Burei; Francesco Rodeghiero
High levels of histidine-rich glycoprotein and thrombotic diathesis. Report of two unrelated families.
Thrombosis research 1993;69(3):297-305.
1993: A M Randi; Elisabetta Sacchi; Giancarlo Castaman; Francesco Rodeghiero; Pier M Mannucci
The genetic defect of type I von Willebrand disease "Vicenza" is linked to the von Willebrand factor gene.
Thrombosis and haemostasis 1993;69(2):173-6.
1992: Giancarlo Castaman; Francesco Rodeghiero
Failure of DDAVP to shorten the prolonged bleeding time of two patients with congenital afibrinogenemia.
Thrombosis research 1992;68(3):309-15.
1992: Giancarlo Castaman; Alberto Tosetto; Francesco Rodeghiero
Effectiveness of high-dose intravenous immunoglobulin in a case of acquired von Willebrand syndrome with chronic melena not responsive to desmopressin and factor VIII concentrate.
American journal of hematology 1992;41(2):132-6.
1992: A Lattuada; P Varanukulsak; Giancarlo Castaman; Pier M Mannucci
The response of plasma von Willebrand factor to desmopressin (DDAVP) is related to the platelet levels of von Willebrand factor.
Thrombosis research 1992;67(4):467-71.
1992: Pier M Mannucci; P M Tenconi; Giancarlo Castaman; F Rodeghiero
Comparison of four virus-inactivated plasma concentrates for treatment of severe von Willebrand disease: a cross-over randomized trial.
Blood 1992;79(12):3130-7.
1992: Francesco Rodeghiero; M Frezzato; C Schiavotto; Giancarlo Castaman; E Dini
Fulminant sepsis in adults splenectomized for idiopathic thrombocytopenic purpura.
Haematologica 1992;77(3):253-6.
1992: Francesco Rodeghiero; C Schiavotto; Giancarlo Castaman; M Vespignani; M Ruggeri; E Dini
A follow-up study of 49 adult patients with idiopathic thrombocytopenic purpura treated with high-dose immunoglobulins and anti-D immunoglobulins.
Haematologica 1992;77(3):248-52.
1992: Francesco Rodeghiero; Giancarlo Castaman; M Ruggeri; Alberto Tosetto
The bleeding time in normal subjects is mainly determined by platelet von Willebrand factor and is independent from blood group.
Thrombosis research 1992;65(4-5):605-15.
1992: Giancarlo Castaman; M Ruggeri; R Girardello; Francesco Rodeghiero
An unusually prolonged case of heparin-induced thrombocytopenia and disseminated intravascular coagulation.
Haematologica 1992;77(2):174-6.
1992: Pier M Mannucci; Armando Tripodi; Bianca Bottasso; F Baudo; G Finazzi; V De Stefano; G Palareti; C Manotti; Maria Gabriella Mazzucconi; Giancarlo Castaman
Markers of procoagulant imbalance in patients with inherited thrombophilic syndromes.
Thrombosis and haemostasis 1992;67(2):200-2.
1992: Francesco Rodeghiero; Giancarlo Castaman; D Meyer; P M Mannucci
Replacement therapy with virus-inactivated plasma concentrates in von Willebrand disease.
Vox sanguinis 1992;62(4):193-9.
1991: Giancarlo Castaman; Francesco Rodeghiero; M Ruggeri; Eros Di Bona; E Dini
Long-lasting remission after high-dose intravenous immunoglobulins in a case of relapsing thrombotic thrombocytopenic purpura.
Haematologica 1991;76(6):511-2.
1991: Francesco Rodeghiero; Giancarlo Castaman; P M Mannucci
Clinical indications for desmopressin (DDAVP) in congenital and acquired von Willebrand disease.
Blood reviews 1991;5(3):155-61.
1991: Francesco Rodeghiero; Giancarlo Castaman; M Ruggeri; M Cazzavillan; G Ferracin; E Dini
Fibrinolytic studies in 13 unrelated families with factor XII deficiency.
Haematologica 1991;76(1):28-32.
1991: Francesco Rodeghiero; Alberto Tosetto; Eros Di Bona; Giancarlo Castaman
Clinical pharmacokinetics of a placenta-derived factor XIII concentrate in type I and type II factor XIII deficiency.
American journal of hematology 1991;36(1):30-4.
1990: Francesco Rodeghiero; Giancarlo Castaman; Alberto Tosetto
von Willebrand factor antigen is less sensitive than ristocetin cofactor for the diagnosis of type I von Willebrand disease--results based on an epidemiological investigation.
Thrombosis and haemostasis 1990;64(3):349-52.
1990: Giancarlo Castaman; Francesco Rodeghiero; E Dini
Thrombotic complications during L-asparaginase treatment for acute lymphocytic leukemia.
Haematologica 1990;75(6):567-9.
1990: Francesco Rodeghiero; Giancarlo Castaman; Alberto Tosetto; A Lattuada; P M Mannucci
Platelet von Willebrand factor assay: results using two methods for platelet lysis.
Thrombosis research 1990;59(2):259-67.
1990: Francesco Rodeghiero; G Avvisati; Giancarlo Castaman; T Barbui; F Mandelli
Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients.
Blood 1990;75(11):2112-7.
1990: Francesco Rodeghiero; Giancarlo Castaman; E Dini
Fibrinopeptide A changes during remission induction treatment with L-asparaginase in acute lymphoblastic leukemia: evidence for activation of blood coagulation.
Thrombosis research 1990;57(1):31-8.
1989: Pier M Mannucci; A Lattuada; Giancarlo Castaman; Rossana Lombardi; M L Colibretti; N Ciavarella; Francesco Rodeghiero
Heterogeneous phenotypes of platelet and plasma von Willebrand factor in obligatory heterozygotes for severe von Willebrand disease.
Blood 1989;74(7):2433-6.
1989: Francesco Rodeghiero; Giancarlo Castaman; Eros Di Bona; M Ruggeri
Consistency of responses to repeated DDAVP infusions in patients with von Willebrand's disease and hemophilia A.
Blood 1989;74(6):1997-2000.
1989: Giancarlo Castaman; M Ruggeri; Francesco Rodeghiero
Increased proteolysis of antithrombin III Vicenza during disseminated intravascular coagulation in acute leukemia.
Thrombosis research 1989;55(5):661-4.
1989: Francesco Rodeghiero; Giancarlo Castaman; Alberto Tosetto; M Ruggeri; Eros Di Bona
Triton X contaminating platelet lysate critically affects the measurement of von Willebrand factor ristocetin cofactor activity.
Thrombosis research 1989;55(4):521-6.
1989: Francesco Rodeghiero; Giancarlo Castaman; Giuliano Soffiati; R Quaglio; S Castronovo; S Cortesi; E Dini
Clinical significance of fibrinopeptide A in acute lymphocytic and non-lymphocytic leukaemia.
Blut 1989;59(2):177-83.
1989: Giancarlo Castaman; Francesco Rodeghiero; Eros Di Bona; M Ruggeri
Clinical effectiveness of desmopressin in a case of acquired von Willebrand's syndrome associated with benign monoclonal gammopathy.
Blut 1989;58(4):211-3.
1988: Francesco Rodeghiero; Giancarlo Castaman; M Vespignani; E Dini; M Bertazzoni
Erythema multiforme after intravenous immunoglobulin.
Blut 1988;56(3):145.
1988: Francesco Rodeghiero; Giancarlo Castaman; Eros Di Bona; M Ruggeri; R Lombardi; P M Mannucci
Hyper-responsiveness to DDAVP for patients with type I von Willebrand's disease and normal intra-platelet von Willebrand factor.
European journal of haematology 1988;40(2):163-7.
1988: Pier M Mannucci; Rossana Lombardi; Giancarlo Castaman; J A Dent; A Lattuada; Francesco Rodeghiero; T S Zimmerman
von Willebrand disease "Vicenza" with larger-than-normal (supranormal) von Willebrand factor multimers.
Blood 1988;71(1):65-70.
1987: Francesco Rodeghiero; Giancarlo Castaman
Calibration of lyophilized standards for ristocetin cofactor activity of von Willebrand Factor (vWF) requires vWF-deficient plasma as diluent for dose-response curves.
Thrombosis and haemostasis 1987;58(4):978-81.
1987: Francesco Rodeghiero; Giancarlo Castaman; Eros Di Bona; M Ruggeri; E Dini
Successful pregnancy in a woman with congenital factor XIII deficiency treated with substitutive therapy. Report of a second case.
Blut 1987;55(1):45-8.
1987: Francesco Rodeghiero; Giancarlo Castaman; A Dal Belin Peruffo; E Dini; A Galletti; E Barone; G Gastaldi
Fibrinogen Vicenza and Genova II: two new cases of congenital dysfibrinogenemia with isolated defect of fibrin monomer polymerization and inhibitory activity on normal coagulation.
Thrombosis and haemostasis 1987;57(3):252-8.
1987: R Vangelisti; D N Rositani; A Pagnacco; Eros Di Bona; Francesco Rodeghiero; Giancarlo Castaman
[Tooth extractions in patients with hemophilia and von Willebrand's disease].
Dental Cadmos 1987;55(1):91-7.
1985: Francesco Rodeghiero; Giancarlo Castaman; T Chisesi; Anita De Rossi; O Dalla Gassa; A Del Mistro; E Dini; S Castronovo; E Pornaro; Luigi Chieco-Bianchi
One year follow-up study of T-cell subsets and incidence of seropositivity for HTLV-I and HTLV-III antibodies in patients treated "on demand" or sporadically with clotting concentrates.
Thrombosis and haemostasis 1985;54(3):665-8.